RLYB - Rallybio Corp
10.8
0.295 2.731%
Share volume: 210,346
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$10.50
0.29
0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-07-2024 | 03-13-2025 | 05-08-2025 | 11-06-2025 | |
| Assets | |||||||
| Total Assets | 99.359 M | 92.431 M | 79.007 M | 68.108 M | 57.983 M | 67.661 M | |
| Current Assets | 98.545 M | 91.436 M | 78.230 M | 67.841 M | 57.381 M | 66.627 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 74.874 M | 71.943 M | 49.819 M | 51.608 M | 39.716 M | 27.197 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 19.301 M | 16.671 M | 25.320 M | 13.903 M | 14.779 M | 32.122 M | |
| Total Non-current Assets | 304.000 K | 568.000 K | 431.000 K | 0.000 | 413.000 K | 0.000 | |
| Property Plant Equipment | 211.000 K | 177.000 K | 145.000 K | 115.000 K | 87.000 K | 26.000 K | |
| Other Assets | 603.000 K | 818.000 K | 632.000 K | 152.000 K | 515.000 K | 1.008 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 99.359 M | 92.431 M | 79.007 M | 68.108 M | 57.983 M | 67.661 M | |
| Total liabilities | 10.202 M | 12.414 M | 8.189 M | 6.454 M | 3.910 M | 4.627 M | |
| Total current liabilities | 10.086 M | 12.161 M | 8.189 M | 6.242 M | 3.910 M | 4.519 M | |
| Accounts Payable | 470.000 K | 1.218 M | 583.000 K | 278.000 K | 400.000 K | 269.000 K | |
| Other liabilities | 116.000 K | 58.000 K | 0.000 | 0.000 | 0.000 | 108.000 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 116.000 K | 58.000 K | 0.000 | 0.000 | 0.000 | 108.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 89.157 M | 80.017 M | 70.818 M | 61.654 M | 54.073 M | 63.034 M | |
| Common stock | 343.502 M | 350.598 M | 352.625 M | 354.606 M | 356.485 M | 359.156 M | |
| Retained earnings | -254.274 M | -270.510 M | -281.976 M | -293.020 M | -302.459 M | -296.146 M |